Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RGNX
RGNX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RGNX News
FDA Leadership Shakeup May Impact Biotech Stocks
2d ago
stocktwits
REGENXBIO to Present Gene Therapy Advances at ASGCT 2026 Meeting
3d ago
PRnewswire
REGENXBIO to Report Q1 2026 Financial Results
4d ago
PRnewswire
REGENXBIO to Report Q1 2026 Financial Results on May 14
4d ago
Newsfilter
Notice of REGENXBIO Securities Class Action
Apr 14 2026
PRnewswire
Capricor's Former Executive Considered for FDA Biologics Chief
Apr 14 2026
stocktwits
Regenxbio Faces Class Action for Securities Fraud
Apr 13 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit Reminder
Apr 13 2026
PRnewswire
REGENXBIO Class Action Lawsuit Notice
Apr 12 2026
Globenewswire
Faruqi & Faruqi Encourages REGENXBIO Investors to Reach Out
Apr 10 2026
PRnewswire
Notice of REGENXBIO Securities Class Action
Apr 09 2026
PRnewswire
Notice of Class Action Lawsuit Against REGENXBIO Securities
Apr 09 2026
Globenewswire
REGENXBIO Faces Class Action Lawsuit Over Securities Violations
Apr 09 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit Reminder
Apr 09 2026
Globenewswire
REGENXBIO Faces Class Action Lawsuit Over Securities Violations
Apr 06 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit Reminder
Apr 06 2026
Globenewswire
Show More News
